226 related articles for article (PubMed ID: 33059768)
1. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals.
Lee DH; Birhanu BT; Lee EB; Lee SJ; Boby N; Park YS; Park SC
Vet Res; 2020 Oct; 51(1):131. PubMed ID: 33059768
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids.
Zhang BX; Lu XX; Gu XY; Li XH; Gu MX; Zhang N; Shen XG; Ding HZ
Vet J; 2014 Mar; 199(3):399-405. PubMed ID: 24423605
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).
Zhao DH; Wang XF; Wang Q; Li LD
BMC Vet Res; 2017 Jul; 13(1):226. PubMed ID: 28754112
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs.
Zhang B; Gu X; Li X; Gu M; Zhang N; Shen X; Li Y; Ding H
J Vet Pharmacol Ther; 2014 Aug; 37(4):367-73. PubMed ID: 24372291
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of ceftiofur against Streptococcus equi subsp zooepidemicus and subsp equi isolated from horses with lower respiratory disease in Europe since 2002.
Bade D; Portis E; Keane C; Hallberg J; Bryson L; Sweeney M; Boner P
Vet Ther; 2009; 10(4):E1-10. PubMed ID: 20425729
[TBL] [Abstract][Full Text] [Related]
8. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs.
Zhou YF; Zhao DH; Yu Y; Yang X; Shi W; Peng YB; Liu YH
J Vet Pharmacol Ther; 2015 Dec; 38(6):543-8. PubMed ID: 25776615
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of cefquinome against equine bacterial pathogens.
Thomas E; Thomas V; Wilhelm C
Vet Microbiol; 2006 Jun; 115(1-3):140-7. PubMed ID: 16455213
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
[TBL] [Abstract][Full Text] [Related]
12. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
[TBL] [Abstract][Full Text] [Related]
13. Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals.
Berghaus LJ; Giguère S; Sturgill TL; Bade D; Malinski TJ; Huang R
J Vet Pharmacol Ther; 2012 Feb; 35(1):59-66. PubMed ID: 21443748
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a single intramuscular injection of cefquinome in buffalo calves.
Venkatachalam D; Dumka VK; Ranjan B
J Vet Pharmacol Ther; 2018 Feb; 41(1):155-158. PubMed ID: 28891215
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
Yu Y; Zhou YF; Chen MR; Li X; Qiao GL; Sun J; Liao XP; Liu YH
PLoS One; 2016; 11(5):e0156273. PubMed ID: 27218674
[TBL] [Abstract][Full Text] [Related]
16. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
[TBL] [Abstract][Full Text] [Related]
17. Ceftiofur susceptibility of Streptococcus equi subsp zooepidemicus isolated from horses in North America between 1989 and 2008.
Bade D; Sibert G; Hallberg J; Portis E; Boucher J; Bryson L
Vet Ther; 2009; 10(4):E1-7. PubMed ID: 20425725
[TBL] [Abstract][Full Text] [Related]
18. Kill Rate and Evaluation of
Zhang L; Xie H; Wang H; Ding H; Zhang G; Hu J
Front Vet Sci; 2021; 8():751957. PubMed ID: 34966804
[TBL] [Abstract][Full Text] [Related]
19. Determination of Susceptibility Breakpoint for Cefquinome against
Mi K; Li M; Sun L; Hou Y; Zhou K; Hao H; Pan Y; Liu Z; Xie C; Huang L
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439008
[No Abstract] [Full Text] [Related]
20. Comparative pharmacokinetics and pharmacokinetic/pharmacodynamic analysis by nonlinear mixed-effects modeling of cefquinome in nonpregnant, pregnant, and lactating goats after intravenous and intramuscular administration.
Litterio NJ; Lorenzutti AM; Zarazaga MDP; Himelfarb MA; San Andrés-Larrea MI; Serrano-Rodríguez JM
J Vet Pharmacol Ther; 2021 Jan; 44(1):68-78. PubMed ID: 32779241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
